Empreendimentos Pague Menos S.A. (PGMN3.SA)
BRL 2.98
(-4.49%)
BRL 2.98
(-4.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 807.67 Million BRL | 0.66% |
| 2022 | 965.84 Million BRL | 47.2% |
| 2021 | 633.05 Million BRL | 45.91% |
| 2020 | 511.13 Million BRL | 3.57% |
| 2019 | 422.27 Million BRL | 253.11% |
| 2018 | 212.5 Million BRL | -39.46% |
| 2017 | 198.8 Million BRL | -24.98% |
| 2016 | 100.48 Million BRL | 481.03% |
| 2015 | 164.88 Million BRL | -131.11% |
| 2014 | 212.56 Million BRL | -31.54% |
| 2013 | 310.48 Million BRL | 17.42% |
| 2012 | 264.41 Million BRL | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 293.09 Million BRL | 55.63% |
| 2024 Q1 | 213.48 Million BRL | -28.23% |
| 2023 Q4 | 231.25 Million BRL | 1.6% |
| 2023 FY | - BRL | 0.66% |
| 2023 Q3 | 227.6 Million BRL | 17.79% |
| 2023 Q1 | 129.03 Million BRL | -52.82% |
| 2023 Q2 | 193.23 Million BRL | 49.75% |
| 2022 FY | - BRL | 47.2% |
| 2022 Q2 | 182.2 Million BRL | 29.78% |
| 2022 Q1 | 140.4 Million BRL | -2.23% |
| 2022 Q3 | 302.58 Million BRL | 66.07% |
| 2022 Q4 | 273.48 Million BRL | -9.62% |
| 2021 FY | - BRL | 45.91% |
| 2021 Q1 | 145.53 Million BRL | 4.8% |
| 2021 Q3 | 142.5 Million BRL | -20.34% |
| 2021 Q4 | 143.61 Million BRL | 0.78% |
| 2021 Q2 | 178.88 Million BRL | 22.92% |
| 2020 Q2 | 112.1 Million BRL | 204.66% |
| 2020 Q4 | 138.86 Million BRL | 6.26% |
| 2020 FY | - BRL | 3.57% |
| 2020 Q3 | 130.67 Million BRL | 16.57% |
| 2020 Q1 | 36.79 Million BRL | -71.05% |
| 2019 Q3 | 131.19 Million BRL | 65.13% |
| 2019 Q1 | 66.24 Million BRL | -46.85% |
| 2019 Q2 | 79.44 Million BRL | 19.93% |
| 2019 FY | - BRL | 253.11% |
| 2019 Q4 | 127.12 Million BRL | -3.11% |
| 2018 Q1 | 26.55 Million BRL | 265.33% |
| 2018 Q3 | 17.5 Million BRL | 129.54% |
| 2018 Q2 | -59.28 Million BRL | -323.23% |
| 2018 FY | - BRL | -39.46% |
| 2018 Q4 | 124.63 Million BRL | 611.82% |
| 2017 Q1 | 50.55 Million BRL | 228.67% |
| 2017 FY | - BRL | -24.98% |
| 2017 Q4 | 7.26 Million BRL | -91.25% |
| 2017 Q3 | 83.08 Million BRL | 72.76% |
| 2017 Q2 | 48.09 Million BRL | -4.87% |
| 2016 Q2 | 101.13 Million BRL | 47.24% |
| 2016 Q3 | 70.66 Million BRL | -30.14% |
| 2016 FY | - BRL | 481.03% |
| 2016 Q4 | -39.29 Million BRL | -155.61% |
| 2016 Q1 | 68.68 Million BRL | 565.56% |
| 2015 Q4 | -14.75 Million BRL | -118.67% |
| 2015 Q3 | 79.03 Million BRL | -27.87% |
| 2015 Q2 | 109.58 Million BRL | 21.57% |
| 2015 FY | - BRL | -131.11% |
| 2015 Q1 | 90.14 Million BRL | -23.05% |
| 2014 Q1 | 65.02 Million BRL | 3.21% |
| 2014 Q3 | 79.07 Million BRL | 14.24% |
| 2014 FY | - BRL | -31.54% |
| 2014 Q4 | 117.14 Million BRL | 48.14% |
| 2014 Q2 | 69.22 Million BRL | 6.45% |
| 2013 FY | - BRL | 17.42% |
| 2013 Q1 | 61.25 Million BRL | 0.0% |
| 2013 Q2 | 74.47 Million BRL | 21.58% |
| 2013 Q3 | 62.25 Million BRL | -16.41% |
| 2013 Q4 | 63 Million BRL | 1.2% |
| 2012 FY | - BRL | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Raia Drogasil S.A. | 3.59 Billion BRL | 77.527% |